Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Ross

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Nature. Mental Health|April 13, 2026
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancerPetros D Petridis, Jack Grinband, Gabrielle Agin-Liebes, et al.
Clinical Oral Investigations|December 22, 2011
Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1Talita Ribeiro Tenório de França, Alessandra de Albuquerque Tavares Carvalho, Valder Barbosa Gomes, et al.
Frontiers in Pharmacology|March 9, 2018
Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderMichael P Bogenschutz, Samantha K Podrebarac, Jessie H Duane, et al.
Journal of Addictive Diseases|July 13, 2011
Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteriaJoseph A Boscarino, Margaret R Rukstalis, Stuart N Hoffman, et al.
Contemporary Clinical Trials|November 4, 2022
Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trialKelley C O'Donnell, Sarah E Mennenga, Lindsey T Owens, et al.
The American Journal of Psychiatry|January 1, 2025
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialBroc A Pagni, Richard J Zeifman, Sarah E Mennenga, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver DistressNoah D Gold, Samantha K Podrebarac, Lindsay A White, et al.
Journal of Psychopharmacology (Oxford, England)|January 10, 2020
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancerGabrielle I Agin-Liebes, Tara Malone, Matthew M Yalch, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
What Is in a Name? The Many Meanings of "Psychedelic"Kelley C O'Donnell, Daniel E Roberts, Terence H W Ching, et al.
International Review of Psychiatry (Abingdon, England)|February 21, 2025
Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directorsMary E Yaden, Terence H W Ching, Noam Goldway, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Nature. Mental Health|April 13, 2026
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancerPetros D Petridis, Jack Grinband, Gabrielle Agin-Liebes, et al.
Clinical Oral Investigations|December 22, 2011
Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1Talita Ribeiro Tenório de França, Alessandra de Albuquerque Tavares Carvalho, Valder Barbosa Gomes, et al.
Frontiers in Pharmacology|March 9, 2018
Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderMichael P Bogenschutz, Samantha K Podrebarac, Jessie H Duane, et al.
Journal of Addictive Diseases|July 13, 2011
Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteriaJoseph A Boscarino, Margaret R Rukstalis, Stuart N Hoffman, et al.
Contemporary Clinical Trials|November 4, 2022
Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trialKelley C O'Donnell, Sarah E Mennenga, Lindsey T Owens, et al.
The American Journal of Psychiatry|January 1, 2025
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialBroc A Pagni, Richard J Zeifman, Sarah E Mennenga, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver DistressNoah D Gold, Samantha K Podrebarac, Lindsay A White, et al.
Journal of Psychopharmacology (Oxford, England)|January 10, 2020
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancerGabrielle I Agin-Liebes, Tara Malone, Matthew M Yalch, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
What Is in a Name? The Many Meanings of "Psychedelic"Kelley C O'Donnell, Daniel E Roberts, Terence H W Ching, et al.
International Review of Psychiatry (Abingdon, England)|February 21, 2025
Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directorsMary E Yaden, Terence H W Ching, Noam Goldway, et al.
Pageof 8